Growth Metrics

Veracyte (VCYT) Operating Leases (2019 - 2026)

Veracyte's Operating Leases history spans 7 years, with the latest figure at $35.6 million for Q4 2025.

  • On a quarterly basis, Operating Leases fell 17.66% to $35.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $35.6 million, a 17.66% decrease, with the full-year FY2025 number at $35.6 million, down 17.66% from a year prior.
  • Operating Leases hit $35.6 million in Q4 2025 for Veracyte, down from $40.5 million in the prior quarter.
  • Over the last five years, Operating Leases for VCYT hit a ceiling of $50.6 million in Q2 2025 and a floor of $7.5 million in Q4 2023.
  • Historically, Operating Leases has averaged $20.7 million across 5 years, with a median of $14.1 million in 2021.
  • Biggest five-year swings in Operating Leases: decreased 29.33% in 2023 and later skyrocketed 474.58% in 2024.
  • Tracing VCYT's Operating Leases over 5 years: stood at $14.1 million in 2021, then dropped by 24.46% to $10.6 million in 2022, then decreased by 29.33% to $7.5 million in 2023, then skyrocketed by 474.58% to $43.2 million in 2024, then dropped by 17.66% to $35.6 million in 2025.
  • Business Quant data shows Operating Leases for VCYT at $35.6 million in Q4 2025, $40.5 million in Q3 2025, and $50.6 million in Q2 2025.